Effectiveness Of The Fibulock Intramedullary Nail

NCT02688296 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2021-01-20

No results posted yet for this study

Summary

The objective of this post-market clinical study is to evaluate efficacy outcomes and complication rates in patients who have received the Fibulock™ Intramedullary Nail.

Conditions

  • Fibula Fracture

Interventions

DEVICE

Fibulock

Fibulock intramedullary implant will be used to repair fibula fractures

Sponsors & Collaborators

  • Arthrex, Inc.

    lead INDUSTRY

Principal Investigators

  • Terrence Philbin, MD · Orthopedic Foot & Ankle

  • Selene Parekh, MD · NCOC

  • Chris Hodgkins, MD · Baptist Health South Florida, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-24
Primary Completion
2020-07-09
Completion
2020-07-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02688296 on ClinicalTrials.gov